Aquarius Surgical Technologies Inc. Stock
Equities
ASTI
CA03842P1009
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | 0.00% |
|
0.00% | +100.00% |
Sales 2022 | 328K 239K | Sales 2023 | 204K 149K | Capitalization | 276K 201K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 14.5 x |
Net Debt 2022 | 3.08M 2.25M | Net Debt 2023 | 3.39M 2.47M | EV / Sales 2023 | 18 x |
P/E ratio 2022 |
-1.93
x | P/E ratio 2023 |
-0.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
3 months | -42.86% | ||
6 months | +100.00% | ||
Current year | +100.00% |
![Extreme 0.02](/images/extremecours_fleche.png)
![Extreme 0.005](/images/extremecours_fleche.png)
![Extreme 0.005](/images/extremecours_fleche.png)
![Extreme 0.005](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
![Extreme 0](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Michael Machika
CEO | Chief Executive Officer | - | - |
Lorne MacFarlane
DFI | Director of Finance/CFO | - | - |
David Hennigar
CHM | Chairman | 84 | 91-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hennigar
CHM | Chairman | 84 | 91-12-31 |
Director/Board Member | - | 15-12-31 | |
Director/Board Member | 64 | - |
Date | Price | Change | Volume |
---|
Delayed Quote Canadian Securities Exchange, June 14, 2024 at 12:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+100.00% | 403K | |
+6.37% | 216B | |
+10.21% | 189B | |
+28.22% | 153B | |
+34.42% | 114B | |
+19.21% | 54.78B | |
+0.13% | 48.47B | |
-4.16% | 38.88B | |
+2.39% | 36.14B | |
+19.65% | 30.23B |
- Stock Market
- Equities
- ASTI Stock